Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TimeSignature: A Universal Method for Robust Detection of Circadian State from Gene Expression

ABSTRACT: TimeSignature: A Universal Method for Robust Detection of Circadian State from Gene Expression

PROVIDER: PRJNA454445 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7088090_1.fastq.gz	Fastqsanger.gz
	SRR7088090_2.fastq.gz	Fastqsanger.gz
	SRR7088100_1.fastq.gz	Fastqsanger.gz
	SRR7088100_2.fastq.gz	Fastqsanger.gz
	SRR7088110_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1224

Similar Datasets

TimeSignature: A Universal Method for Robust Detection of Circadian State from Gene Expression

Project description:Profiles of circadian gene expression in whole blood from 11 healthy adult subjects. Abstract: Circadian clocks play a key role in regulating a vast array of biological processes, with significant implications for human health. Accurate assessment of physiological time using transcriptional biomarkers found in human blood can significantly improve diagnosis of circadian disorders and optimize the delivery time of therapeutic treatments. To be useful, such a test must be accurate, minimally burden some to the patient, and readily generalizable to new data. A major obstacle in development of gene expression biomarker tests is the diversity of measurement platforms and the inherent variability of the data, often resulting in predictors that perform well in the original datasets but cannot be universally applied to new samples collected in other settings. Here we introduce TimeSignature, a new algorithm that robustly infers circadian time from gene expression. We demonstrate its application in data from three independent studies using Pdistinct microarrays, and further validate it against a new set of samples profiled by RNA-Seq. Our results show that TimeSignature is more accurate and efficient than competing methods, estimating circadian time to within 2h for the majority of samples. Importantly, we demonstrate that once trained on data from a single study, the resulting predictor can be universally applied to yield highly accurate results in new data from other studies independent of differences in study population, patient protocol, or assay platform without renormalizing the data or retraining. This feature is unique amongst expression–based predictors, and addresses a major challenge in the development of generalizable, clinically–useful tests.

2018-10-08 | GSE113883 | GEO

Universal method for robust detection of circadian state from gene expression.

Project description:Circadian clocks play a key role in regulating a vast array of biological processes, with significant implications for human health. Accurate assessment of physiological time using transcriptional biomarkers found in human blood can significantly improve diagnosis of circadian disorders and optimize the delivery time of therapeutic treatments. To be useful, such a test must be accurate, minimally burdensome to the patient, and readily generalizable to new data. A major obstacle in development of gene expression biomarker tests is the diversity of measurement platforms and the inherent variability of the data, often resulting in predictors that perform well in the original datasets but cannot be universally applied to new samples collected in other settings. Here, we introduce TimeSignature, an algorithm that robustly infers circadian time from gene expression. We demonstrate its application in data from three independent studies using distinct microarrays and further validate it against a new set of samples profiled by RNA-sequencing. Our results show that TimeSignature is more accurate and efficient than competing methods, estimating circadian time to within 2 h for the majority of samples. Importantly, we demonstrate that once trained on data from a single study, the resulting predictor can be universally applied to yield highly accurate results in new data from other studies independent of differences in study population, patient protocol, or assay platform without renormalizing the data or retraining. This feature is unique among expression-based predictors and addresses a major challenge in the development of generalizable, clinically useful tests.

| S-EPMC6166804 | biostudies-literature

Super cChIP-seq, a robust and universal epigenetic profiling method using 10 cells

Project description:Super cChIP-seq, a robust and universal epigenetic profiling method using 10 cells

| PRJNA562718 | ENA

Super cChIP-seq, a robust and universal epigenetic profiling method using 10 cells

Project description:ChIP-seq is the standard technique to characterize the genome-wide epigenomic modifications, which requires millions of cells as starting material. Although some methods have recently reported to be suitable for epigenomic profiling with a small number of cells, there are still no methods capable of profiling both histone modifications and DNA methylation with extremely low input. Here, we developed a new method by supplementing carrier materials of chemically modified epigenetic markers and dUPT-containing DNA fragments during ChIP procedures. Using this strategy, we generated high-quality epigenomic profiles of both histone modifications (super cChIP-seq) and DNA methylation (super cMeDIP-seq) with as few as 10 cells. Thus, we provide a robust and straightforward universal approach for epigenomic profiling starting with extremely low input.

2024-04-07 | GSE136578 | GEO

A rapid and robust method for Mitochondrial DNA profiling

Project description:A rapid and robust method for Mitochondrial DNA profiling

| PRJNA1108319 | ENA

ChEC-Seq: a robust method to identify protein-DNA interactions genome-wide

Project description:ChEC-Seq: a robust method to identify protein-DNA interactions genome-wide

| PRJNA552083 | ENA

Universal Solid-Phase Protein Preparation (USP3) for bottom-up and top-down proteomics

Project description:Selecting a sample preparation strategy for mass spectrometry-based proteomics is critical to the success of quantitative workflows. Here we present a universal, solid-phase protein preparation (USP3) method which is rapid, robust and scalable, facilitating high-throughput protein sample preparation for bottom-up and top-down mass spectrometry (MS) analysis.

2019-06-05 | PXD011169 | Pride

CoolMPS for robust sequencing of single-nuclear RNAs captured by droplet-based method

Project description:CoolMPS for robust sequencing of single-nuclear RNAs captured by droplet-based method

| PRJNA631718 | ENA

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

Project description:This clinical trial studies universal screening for deoxyribonucleic acid (DNA) mismatch repair deficiency in patients with endometrial cancer, mutations in the genes responsible for Lynch syndrome (inherited forms of endometrial cancers) and other DNA changes that could help guide treatment strategies. Universal tumor DNA sequencing may help doctors better understand how to personalize care, increase length of life, and increase quality of life in patients with endometrial cancer and their relatives.

| 2267967 | ecrin-mdr-crc

Towards a universal sample preparation method for denaturing top-down proteomics of complex proteomes

Project description:A universal and standardized sample preparation method becomes vital for denaturing top-down proteomics (dTDP) to advance the scale and accuracy of proteoform delineation in complex biological systems. It needs to have high protein recovery, minimum bias, good reproducibility, and compatibility with downstream mass spectrometry (MS) analysis. Here we employed a lysis buffer containing sodium dodecyl sulfate (SDS) for extracting proteoforms from cells, and for the first time, compared membrane ultrafiltration (MU), chloroform-methanol precipitation (CMP), and single-spot solid-phase sample preparation using magnetic beads (SP3) for proteoform cleanup for dTDP. The MU method outperformed CMP and SP3 methods, resulting in high and reproducible protein recovery from both E. coli cell (59±3%) and human HepG2 cell (86±5%) samples without a significant bias. Single-shot capillary zone electrophoresis (CZE)-MS/MS analyses of the prepared E. coli and HepG2 cell samples using the MU method identified 821 and 516 proteoforms, respectively. Nearly 30% and 50% of the identified E. coli and HepG2 proteins are membrane proteins. CZE-MS/MS identified 94 histone proteoforms from the HepG2 sample with various post-translational modifications, including acetylation, methylation, and phosphorylation. Our results suggest that combining the SDS-based protein extraction and the MU-based protein cleanup could be a universal sample preparation method for dTDP.

2020-05-22 | PXD018248 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data